Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1989 Feb;59(2):261–267. doi: 10.1038/bjc.1989.55

Prognosis of conjunctival melanomas in relation to histopathological features.

U Fuchs 1, T Kivelä 1, K Liesto 1, A Tarkkanen 1
PMCID: PMC2246983  PMID: 2649132

Abstract

Twenty-six patients (age 29-85 years) with primary malignant melanoma of the conjunctiva were analysed for usefulness of various histopathological and immunohistochemical features of the primary, recurrent and metastatic tumours in evaluating their prognosis. The mean follow-up time was 5.5 years, ranging from 8 months to 17 years. Eight patients developed metastases and seven have died. The mean time from diagnosis to death due to metastasis was 3.8 years (range 1-6 years). The site of the primary tumour seemed to be most closely correlated to high metastatic risk. Only two of the sixteen limbal melanomas metastasised, whereas two of the four bulbar, all three tarsal and the only diffuse primary tumour caused metastatic disease. Two of the metastasising primary tumours were less than 1.5 mm thick, but all exceeded 0.8 mm in thickness. The mitotic rate, the amount of inflammatory infiltrate, the cell type or the presence of adjacent intraepithelial involvement did not obviously correlate to treatment outcome. Furthermore, the expression of S-100 protein and neuron-specific enolase (NSE), both suggested to be prognostic indicators in cutaneous melanoma, did not correlate to the tendency of the conjunctival melanomas to recur or metastasise.

Full text

PDF
261

Images in this article

265Figure 2
on p.265

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Benderitter T., Berard M., Bonerandi J. J., Lebreuil G. Les proliférations mélaniques de la conjonctive. Etude histopathologique à propos d'une série de 40 cas. J Fr Ophtalmol. 1985;8(5):411–422. [PubMed] [Google Scholar]
  2. Cochran A. J., Holland G. N., Wen D. R., Herschman H. R., Lee W. R., Foos R. Y., Straatsma B. R. Detection of cytoplasmic S-100 protein in primary and metastatic intraocular melanomas. Invest Ophthalmol Vis Sci. 1983 Aug;24(8):1153–1155. [PubMed] [Google Scholar]
  3. Cochran A. J., Wen D. R., Herschman H. R., Gaynor R. B. Detection of S-100 protein as an aid to the identification of melanocytic tumors. Int J Cancer. 1982 Sep 15;30(3):295–297. doi: 10.1002/ijc.2910300307. [DOI] [PubMed] [Google Scholar]
  4. Crawford J. B. Conjunctival melanomas: prognostic factors a review and an analysis of a series. Trans Am Ophthalmol Soc. 1980;78:467–502. [PMC free article] [PubMed] [Google Scholar]
  5. Dhillon A. P., Rode J. Patterns of staining for neurone specific enolase in benign and malignant melanocytic lesions of the skin. Diagn Histopathol. 1982 Jul-Sep;5(3):169–174. [PubMed] [Google Scholar]
  6. Folberg R., McLean I. W., Zimmerman L. E. Malignant melanoma of the conjunctiva. Hum Pathol. 1985 Feb;16(2):136–143. doi: 10.1016/s0046-8177(85)80062-9. [DOI] [PubMed] [Google Scholar]
  7. Folberg R., McLean I. W., Zimmerman L. E. Primary acquired melanosis of the conjunctiva. Hum Pathol. 1985 Feb;16(2):129–135. doi: 10.1016/s0046-8177(85)80061-7. [DOI] [PubMed] [Google Scholar]
  8. Fuchs U., Kivelä T., Tarkkanen A., Laatikainen L. Histopathology of enucleated intraocular melanomas irradiated with cobalt and ruthenium plaques. Acta Ophthalmol (Copenh) 1988 Jun;66(3):255–266. doi: 10.1111/j.1755-3768.1988.tb04594.x. [DOI] [PubMed] [Google Scholar]
  9. Garrido C. M., Arra A. Value of the S100 protein in the study of nevus and ocular melanomas. Ophthalmologica. 1987;194(4):201–203. doi: 10.1159/000309766. [DOI] [PubMed] [Google Scholar]
  10. Grossniklaus H. E., Green W. R., Luckenbach M., Chan C. C. Conjunctival lesions in adults. A clinical and histopathologic review. Cornea. 1987;6(2):78–116. doi: 10.1097/00003226-198706020-00002. [DOI] [PubMed] [Google Scholar]
  11. Guillén F. J., Albert D. M., Mihm M. C., Jr Pigmented melanocytic lesions of the conjunctiva--a new approach to their classification. Pathology. 1985 Apr;17(2):275–280. doi: 10.3109/00313028509063767. [DOI] [PubMed] [Google Scholar]
  12. Hachisuka H., Sakamoto F., Nomura H., Mori O., Sasai Y. Immunohistochemical study of S-100 protein and neuron specific enolase (NSE) in melanocytes and the related tumors. Acta Histochem. 1986;80(2):215–223. doi: 10.1016/S0065-1281(86)80066-6. [DOI] [PubMed] [Google Scholar]
  13. Haimoto H., Hosoda S., Kato K. Differential distribution of immunoreactive S100-alpha and S100-beta proteins in normal nonnervous human tissues. Lab Invest. 1987 Nov;57(5):489–498. [PubMed] [Google Scholar]
  14. Haimoto H., Takahashi Y., Koshikawa T., Nagura H., Kato K. Immunohistochemical localization of gamma-enolase in normal human tissues other than nervous and neuroendocrine tissues. Lab Invest. 1985 Mar;52(3):257–263. [PubMed] [Google Scholar]
  15. Hirano T. Immunohistochemical study of malignant melanoma. Acta Pathol Jpn. 1986 May;36(5):733–743. doi: 10.1111/j.1440-1827.1986.tb01060.x. [DOI] [PubMed] [Google Scholar]
  16. Holbach L., Hofmann C. S-100 Protein in nicht-pigmentierten melanozytären und neuroektodermalen Tumoren der Konjunktiva. Klin Monbl Augenheilkd. 1987 Feb;190(2):105–108. doi: 10.1055/s-2008-1050338. [DOI] [PubMed] [Google Scholar]
  17. Isaacson P. G., Jones D. B. Immunohistochemical differentiation between histiocytic and lymphoid neoplasms. Histochem J. 1983 Jul;15(7):621–635. doi: 10.1007/BF01002984. [DOI] [PubMed] [Google Scholar]
  18. JAY B. NAEVI AND MELANOMATA OF THE CONJUNCTIVA. Br J Ophthalmol. 1965 Apr;49:169–204. doi: 10.1136/bjo.49.4.169. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Jeffrey I. J., Lucas D. R., McEwan C., Lee W. R. Malignant melanoma of the conjunctiva. Histopathology. 1986 Apr;10(4):363–378. doi: 10.1111/j.1365-2559.1986.tb02490.x. [DOI] [PubMed] [Google Scholar]
  20. Kahn H. J., Marks A., Thom H., Baumal R. Role of antibody to S100 protein in diagnostic pathology. Am J Clin Pathol. 1983 Mar;79(3):341–347. doi: 10.1093/ajcp/79.3.341. [DOI] [PubMed] [Google Scholar]
  21. Kernohan N. M., Rankin R. S-100 protein: a prognostic indicator in cutaneous malignant melanoma? Histopathology. 1987 Dec;11(12):1285–1293. doi: 10.1111/j.1365-2559.1987.tb01873.x. [DOI] [PubMed] [Google Scholar]
  22. Kindblom L. G., Lodding P., Rosengren L., Baudier J., Haglid K. S-100 protein in melanocytic tumors. An immunohistochemical investigation of benign and malignant melanocytic tumors and metastases of malignant melanoma and a characterization of the antigen in comparison to human brain. Acta Pathol Microbiol Immunol Scand A. 1984 Jul;92(4):219–230. [PubMed] [Google Scholar]
  23. Liesegang T. J., Campbell R. J. Mayo Clinic experience with conjunctival melanomas. Arch Ophthalmol. 1980 Aug;98(8):1385–1389. doi: 10.1001/archopht.1980.01020040237004. [DOI] [PubMed] [Google Scholar]
  24. Margo C. E., Lavellée M. Gamma-enolase activity in choroidal melanoma. Graefes Arch Clin Exp Ophthalmol. 1986;224(4):374–376. doi: 10.1007/BF02150033. [DOI] [PubMed] [Google Scholar]
  25. McGhee C. N., Ni C., Albert D. M., Chu F. R. Conjunctival melanoma. Int Ophthalmol Clin. 1982 Fall;22(3):35–56. doi: 10.1097/00004397-198202230-00006. [DOI] [PubMed] [Google Scholar]
  26. Nakajima T., Watanabe S., Sato Y., Kameya T., Shimosato Y., Ishihara K. Immunohistochemical demonstration of S100 protein in malignant melanoma and pigmented nevus, and its diagnostic application. Cancer. 1982 Sep 1;50(5):912–918. doi: 10.1002/1097-0142(19820901)50:5<912::aid-cncr2820500519>3.0.co;2-u. [DOI] [PubMed] [Google Scholar]
  27. Rode J., Dhillon A. P. Neurone specific enolase and S100 protein as possible prognostic indicators in melanoma. Histopathology. 1984 Nov;8(6):1041–1052. doi: 10.1111/j.1365-2559.1984.tb02419.x. [DOI] [PubMed] [Google Scholar]
  28. Royds J. A., Parsons M. A., Rennie I. G., Timperley W. R., Taylor C. B. Enolase isoenzymes in benign and malignant melanocytic lesions. Diagn Histopathol. 1982 Jul-Sep;5(3):175–181. [PubMed] [Google Scholar]
  29. Royds J. A., Rennie I. G., Parsons M. A., Timperley W. R., Taylor C. B. Enolase isoenzymes in uveal melanomas--a possible parameter of malignancy. Br J Ophthalmol. 1983 Apr;67(4):244–248. doi: 10.1136/bjo.67.4.244. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Springall D. R., Gu J., Cocchia D., Michetti F., Levene A., Levene M. M., Marangos P. J., Bloom S. R., Polak J. M. The value of S-100 immunostaining as a diagnostic tool in human malignant melanomas. A comparative study using S-100 and neuron-specific enolase antibodies. Virchows Arch A Pathol Anat Histopathol. 1983;400(3):331–343. doi: 10.1007/BF00612194. [DOI] [PubMed] [Google Scholar]
  31. Stefani F. H. Das maligne Melanom der Bindehaut--Klinischer Verlauf und histopathologischer Befund. Fortschr Ophthalmol. 1986;83(1):141–145. [PubMed] [Google Scholar]
  32. Thomas P., Battifora H., Manderino G. L., Patrick J. A monoclonal antibody against neuron-specific enolase. Immunohistochemical comparison with a polyclonal antiserum. Am J Clin Pathol. 1987 Aug;88(2):146–152. doi: 10.1093/ajcp/88.2.146. [DOI] [PubMed] [Google Scholar]
  33. Vanstapel M. J., Gatter K. C., de Wolf-Peeters C., Mason D. Y., Desmet V. D. New sites of human S-100 immunoreactivity detected with monoclonal antibodies. Am J Clin Pathol. 1986 Feb;85(2):160–168. doi: 10.1093/ajcp/85.2.160. [DOI] [PubMed] [Google Scholar]
  34. Vanstapel M. J., Peeters B., Cordell J., Heyns W., De Wolf-Peeters C., Desmet V., Mason D. Production of monoclonal antibodies directed against antigenic determinants common to the alpha- and beta-chain of bovine brain S-100 protein. Lab Invest. 1985 Feb;52(2):232–238. [PubMed] [Google Scholar]
  35. Vinores S. A., Bonnin J. M., Rubinstein L. J., Marangos P. J. Immunohistochemical demonstration of neuron-specific enolase in neoplasms of the CNS and other tissues. Arch Pathol Lab Med. 1984 Jul;108(7):536–540. [PubMed] [Google Scholar]
  36. Warnke R. A., Gatter K. C., Falini B., Hildreth P., Woolston R. E., Pulford K., Cordell J. L., Cohen B., De Wolf-Peeters C., Mason D. Y. Diagnosis of human lymphoma with monoclonal antileukocyte antibodies. N Engl J Med. 1983 Nov 24;309(21):1275–1281. doi: 10.1056/NEJM198311243092102. [DOI] [PubMed] [Google Scholar]
  37. Williams R. A., Rode J., Dhillon A. P., Jarvis L. R., Skinner J. M., Jamal O. Measuring S100 protein and neurone specific enolase in melanocytic tumours using video image analysis. J Clin Pathol. 1986 Oct;39(10):1096–1098. doi: 10.1136/jcp.39.10.1096. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES